A carregar...

Economic Burden of Chronic Lymphocytic Leukemia in the Era of Oral Targeted Therapies in the United States

PURPOSE: Oral targeted therapies represent a significant advance for the treatment of patients with chronic lymphocytic leukemia (CLL); however, their high cost has raised concerns about affordability and the economic impact on society. Our objective was to project the future prevalence and cost bur...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Clin Oncol
Main Authors: Chen, Qiushi, Jain, Nitin, Ayer, Turgay, Wierda, William G., Flowers, Christopher R., O’Brien, Susan M., Keating, Michael J., Kantarjian, Hagop M., Chhatwal, Jagpreet
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Clinical Oncology 2017
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5559889/
https://ncbi.nlm.nih.gov/pubmed/27870563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2016.68.2856
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!